|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 06011207.5 (espacenet) (Federated) (European Patent Register), 20001115 | | Patent/reg. no. and date | DK/EP 1690536, 20080514 | | Publication date | 20060816 | | Priority no. and date | DE 19955190, 19991116 | | EP pub. no. and date |
EP 1690536 20060816 | | Effective date | | | Applicant/owner | UCB Pharma GmbH, Alfred-Nobel-Strasse 10
40789 Monheim, DE | | Applicant ref. no. | P80826589DK00E | | Inventor | MEESE, Claus, Kreuzbergerstrasse 50
40789 Monheim, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/222 (2006.01) , A61P 13/06 (2006.01) | | Title | Anvendelse af R-( )-2-(3-diisopropylamino-1-phenylpropyl)4-4-hydroxy-methyl-phenylsobutyrat hydrogenfumarat til behandling af urininkontinens og andre spasmogene lidelser | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
